Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging

Annals of Oncology

Volumn 24, Issue 11, 2013, Pages 2866-2870

  Darwiche, K ^a   Zarogoulidis, P ^b   Baehner, K ^a   Welter, S ^a   Tetzner, R ^c   Wohlschlaeger, J ^a   Theegarten, D ^a   Nakajima, T ^d   Freitag, L ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c EPIGENOMICS AG   (Germany)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

DNA methylation; Lung cancer; Shox2

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHOSCOPE; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; ENDOBRONCHIAL ULTRASONOGRAPHY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SHOX2 GENE; STANDARD; TRANSBRONCHIAL ASPIRATION; TUMOR GENE; ULTRASOUND SCANNER;

DNA METHYLATION; LUNG CANCER; SHOX2;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOSCOPES; DNA METHYLATION; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; FEMALE; FOLLOW-UP STUDIES; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 84887034056     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt365     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
2. Rosell R et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994; 330(3): 153-158.
3. Albain KS et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13(8): 1880-1892.
4. Eberhardt W et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 1998; 16(2): 622-634.
5. Yasufuku K et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011; 142(6): 1393-1400.
6. Varela-Lema L, Fernandez-Villar A, Ruano-Ravina A. Effectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration: a systematic review. Eur Respir J 2009; 33(5): 1156-1164.
7. Herth FJ et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006; 61(9): 795-798.
8. Groth SS, Andrade RS. Endobronchial and endoscopic ultrasound-guided fineneedle aspiration: a must for thoracic surgeons. Ann Thorac Surg 2010; 89(6): S2079-S2083.
9. Annema JT et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010; 304(20): 2245-2252.
10. Ehrich M et al. Cytosine methylation profiles as a molecular marker in non-small cell lung cancer. Cancer Res 2006; 66(22): 10911-10918.
11. Belinsky SA et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006; 66(6): 3338-3344.
12. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349(21): 2042-2054.
13. Schneider KU et al. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer 2011; 11: 102.
14. Schmidt B et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 2010; 10: 600.
15. Herth FJ et al. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest 2008; 133(4): 887-891.
16. Yasufuku K et al. Role of endobronchial ultrasound-guided transbronchial needle aspiration in the management of lung cancer. Gen Thorac Cardiovasc Surg 2008; 56(6): 268-276.
17. Yasufuku K et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest 2004; 126(1): 122-128.
18. Yasufuku K et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 2006; 130(3): 710-718.
19. Hwangbo B et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2009; 135(5): 1280-1287.
20. Cucuruz B et al. MAGE qPCR improves the sensitivity and accuracy of EBUS-TBNA for the detection of lymphatic cancer spread. J Thorac Oncol 2012; 7(4): 690-697.
21. Cerfolio RJ et al. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg 2010; 90(2): 427-434.
22. Verhagen AF et al. The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer. J Thorac Oncol 2010; 5(8): 1201-1205.
23. Hashimoto T et al. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res 2000; 60 (22): 6472-6478.
24. Harden SV et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 2003; 9(4): 1370-1375.
25. Izbicki JR et al. Mode of spread in the early phase of lymphatic metastasis in nonsmall-cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 1996; 112(3): 623-630.
26. Dobashi K et al. Micrometastatic P53-positive cells in the lymph nodes of nonsmall-cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg 1997; 114(3): 339-346.
27. Xi L et al. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res 2006; 12(8): 2484-2491.
28. Wang XT et al. Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR. Eur J Cardiothorac Surg 2005; 28(1): 26-32.
29. Inoue M et al. An accurate and rapid detection of lymph node metastasis in nonsmall cell lung cancer patients based on one-step nucleic acid amplification assay. Lung Cancer 2012; 78(3): 212-218.
30. Wallace MB et al. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest 2005; 127(2): 430-437.
31. Pellise M et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonographyguided fine-needle aspiration biopsy. Clin Cancer Res 2004; 10(13): 4444-4449.
32. Steinfort DP et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the evaluation of suspected lymphoma. J Thorac Oncol 2010; 5(6): 804-809.
33. Rahmatpanah FB et al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 2009; 1(1): 39-61.
34. Dietrich D et al. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients. Diagn Mol Pathol 2012; 21(2): 93-104.